Synapse Global Theranostics Inc.

Synapse Global Theranostics offers comprehensive cyclotron technology transfer programs featuring IONETIX ION-12SC access, clinical research infrastructure, and regulatory expertise to unlock the $9 billion global theranostics market.

Center for Genomic Interpretation

The Center for Genomic Interpretation (CGI) is an independent non-profit organization with the mission to save and improve lives through encouraging careful stewardship of clinical genetics, genomics, and precision medicine.

genoloam

GENOLOAM OÜ is a healthcare service provider in three main areas: incubation and joint venture, research and commercialization and comprehensive solution provision. We combine advanced medical technologies and non-medical fields ranging from Biotechnology to Information Technology and Artificial Intelligence in order to provide better Prevention, Diagnostics, Treatment and Care. Our comprehensive health solution service includes sales of innovative diagnostic reagents or examination devices in healthcare, and the management of most accurate screening equipment, reagents, and consumables. Over the years, we have established strong relationships with leading healthcare companies worldwide to support everyone’s exact health situation and needs. GENOLOAM is here for you. For more information on our services and products, please visit www.genoloam.com

FLYING HORSE MEDICAL CENTER

As a full-service primary care family practice, we offer wellness services including Concierge Medicine, Functional Medicine, Bio-Identical Hormone Replacement Therapy (BHRT) and Anti-Aging Aesthetics.

Mission: Cure

Mission: Cure aims to demonstrate a new, faster model for curing diseases using innovative financing based on patient outcomes, starting with chronic pancreatitis. Chronic and recurrent acute pancreatitis is a devastating disease, and we are fighting for a cure. As a coalition of doctors, researchers, patients, and entrepreneurs, we are pioneering a new approach to curing this disease through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.